Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [ID6736]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Emactuzumab for treating localised or diffuse tenosynovial giant cell tumours when surgery is unsuitable [TSID12377]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC